Healthtech & Wellness VC Funds

Wa’ed Ventures is a $500 million venture capital fund established by Saudi Aramco to promote innovation and economic diversification in Saudi Arabia. The fund focuses on investing in tech-based startups, particularly those involved in sustainability, digitalization, and social impact. Its portfolio includes companies such as Red Sea Farms, which develops sustainable agricultural technology for harsh environments, and Mighty Buildings, a leader in modular construction and 3D printing aimed at reducing housing shortages and environmental impact. Wa’ed Ventures primarily invests in early-stage and growth-stage startups, offering strategic guidance and funding. The average investment ranges between $2 million and $5 million, though the firm is also capable of supporting larger, later-stage investments. Its strategy aligns with Saudi Arabia’s Vision 2030, aiming to foster innovation that contributes to economic diversification, particularly in industries like fintech, logistics, AI, and health tech. Startups interested in partnering with Wa’ed Ventures should demonstrate clear scalability, robust technology, and a strong focus on sustainability. The firm prefers to lead funding rounds and plays a hands-on role in helping its portfolio companies navigate regulatory landscapes and market challenges. The team, led by experienced professionals from sectors like finance and technology, offers significant strategic support to help startups grow and succeed. Wa’ed Ventures is a crucial player in Saudi Arabia’s venture ecosystem, supporting the country's transformation into a tech-driven economy while aligning with global sustainability goals.

Wakestream Ventures is a Grand Rapids, Michigan-based early-stage venture capital firm founded in 2012, originally as an investment arm associated with the Start Garden entrepreneurship platform and now operated as a standalone fund. The firm is founded and led by CEO Rick DeVos, a Michigan civic entrepreneur and founder of ArtPrize, alongside Chief Investment Officer Mike DeVries, Partner Kim Pasquino and Entrepreneur in Residence Benjamin Gott. Wakestream's thesis explicitly mines the Midwest's deep operating bench in industrial design, advanced manufacturing, and global enterprise distribution: the firm backs 'fascinating founders' building at the intersection of physical products and the internet, IoT, connected devices, vertical SaaS for legacy industries, medical devices, mobility and industrial automation, and it is willing to lead. Initial check sizes range from $150K to $500K with cumulative follow-on commitments of up to $1.5M across Seed, Series A and Series B rounds. Across 50 disclosed portfolio companies and 14 acquisitions plus one IPO, named outcomes include Shoulder Innovations, whose Series A Wakestream led and which IPO'd on the NYSE in July 2025 at a $299M market cap, Work Truck Solutions, the firm's most recent exit in March 2025, and Jiobit, the children's and pets GPS tracker acquired by Life360. Recent new investments include space ground-station company ATLAS Space Operations, a Series B-II in September 2024, and pinball IoT company Scorbit in November 2025. By mining the Midwest's manufacturing and distribution strengths, Wakestream Ventures backs founders building at the intersection of physical products and the internet.

Walnut Ventures is a distinguished group of experienced entrepreneurs and executives dedicated to investing in and mentoring seed and early-stage companies, particularly those with technology-based B2B or B2C products. The firm is primarily based in the New England area and focuses on industries such as information technology and software. Notable investments by Walnut Ventures include Flexport, PsiQuantum, and Superhuman, reflecting their strong interest in innovative and high-growth sectors. Their geographic focus remains within the United States, with a significant emphasis on the New England region. Walnut Ventures has been actively investing, with 39 companies pitching to them in 2020, leading to investments in 11 of them after thorough due diligence. Walnut Ventures typically leads or co-invests in seed rounds, with a preference for collaboration during due diligence and syndication with other angel groups. The firm’s investment strategy includes offering not just capital but also valuable mentorship and strategic advice in sales, marketing, and fundraising. Their approach ensures that portfolio companies benefit from a robust support network, including introductions to other investors and associates who can assist with various business needs​. The team at Walnut Ventures includes highly accomplished individuals who have founded or led over 20 companies, invested in more than 250 companies, and sat on the boards of over 120 companies. This extensive experience enables them to provide exceptional guidance and support to emerging startups. Additionally, as an AWS Activate Provider, Walnut Ventures offers its portfolio companies access to AWS cloud credits and business support, further aiding their growth and development.

Walter Ventures is a transatlantic enterprise-software-focused venture capital firm founded in 2018 by Isabelle Somers as the venture arm of Canada's Walter Group, the diversified private investment platform headquartered in Westmount, Quebec. The fund operates from a multi-hub footprint with offices in Barcelona, Munich and Westmount, allowing it to source and co-invest seamlessly across Europe and North America. The thesis is sharply focused on Late Seed and Series A B2B software companies that meaningfully change productivity or information-security outcomes for the enterprise, with particular emphasis on healthcare technology, identity and trust, industrial automation, legal and HR tooling, ESG reporting, and AI-driven verticalization of manufacturing, generally as a co-investor. Beyond capital, Walter Ventures pitches itself as a partnership-oriented investor that prioritizes the socio-economic and environmental impact of its companies, and the broader Walter Group provides operational ballast, follow-on capital and trans-Atlantic introductions. The portfolio is concentrated, approximately 10 companies, but high-quality, including unicorn identity-verification platform Incode, where Walter participated in its Series A in March 2021, industrial automation platform Vention, legal and in-house-counsel SaaS DiliTrust, energy player VoltaGrid, and Canadian virtual-care company Dialogue, Walter's exit company, which completed an IPO and was later acquired in July 2023 by Sun Life Financial for $277 million. The team is intentionally compact at five people, two partners, one venture partner and one principal, spanning Spain, the UK and Canada. By operating across Europe and North America, Walter Ventures backs late-seed and Series A B2B software founders improving enterprise productivity and security.

Wamda Capital is a leading venture capital firm focused on fostering entrepreneurship in the Middle East, North Africa, and Turkey (MENAT) region. Established in 2014 by Fadi Ghandour, the founder of Aramex, Wamda has invested in over 100 startups, including notable names like Careem, Souq, and Mumzworld. These companies have been critical in shaping the tech ecosystem in the region, with Careem being one of its standout exits following its acquisition by Uber. Wamda Capital’s investment strategy is sector-agnostic, with a particular focus on technology and tech-enabled businesses. The firm typically invests in Seed to Series A rounds, but it also has a flexible approach through its evergreen investment structure, allowing for both early-stage and opportunistic investments. Its portfolio spans industries such as fintech, e-commerce, and digital health, with recent investments in companies like Tabby (fintech) and Insider (AI-based marketing). Wamda is headquartered in Dubai and is well-known for its hands-on approach, working closely with founders to provide strategic guidance, network connections, and access to growth capital. They emphasize scalability and innovation, making them a strong partner for startups aiming to expand across the MENA region. Led by experienced professionals like Fadi Ghandour and Fares Ghandour, Wamda Capital provides not only capital but also deep regional expertise, making it a pivotal player in the MENAT startup landscape.

WaterBridge Ventures is a SEBI-registered Indian early-stage venture capital firm founded in 2017 with offices in New Delhi and Bengaluru. The firm passionately supports tech-driven, India-centric startups across eight strategic sectors, Manufacturing Tech, Health Tech, Deep Tech, Consumer Tech, Global SaaS, Financial Services, Education Tech and Climate Tech, and enters at the Seed to Series A stage with strong follow-on participation through later rounds, willing to lead. WaterBridge raised its $30 million maiden Fund I in 2018 and marked the final close of Fund II at $150 million, roughly INR 1,112 crore, enabling check sizes of $500K to $3M, up from Fund I's typical INR 3 to 4 crore tickets, across approximately 25 portfolio companies per fund, with capital reserved for follow-ons. The firm is led by Co-Founder and Partner Manish Kheterpal, alongside Partners Sarbvir Singh, Ravi Kaushik, Ashish Jain and Anjali Sosale, with a supporting team including Vice President Sapna Goyal, Investments lead Raj Nayan Datta and Fund Operations lead Karan Kapoor. Across roughly 37 companies invested as of December 2025, the portfolio includes Atlan, a modern data catalog that raised a $105M Series C in 2024 led by GIC and Meritech Capital, Magicpin in commerce loyalty, Chalo in urban bus mobility, Unacademy, CityMall, Bijnis, Eloelo, DataWeave and ZipLoan. Notable exits include DoubtNut, acquired by Allen Career Institute in 2023. By backing India-centric founders across eight strategic sectors from seed to Series A with strong follow-on support, WaterBridge Ventures has built a diversified early-stage technology portfolio.

Wave Capital, founded in 2017 and based in San Francisco, is a venture capital firm that specializes in early-stage investments, particularly in companies that are building marketplaces. The firm was co-founded by Riley Newman, Sara Adler, and David Rosenthal, who bring deep expertise from their experiences at companies like Airbnb and Madrona Venture Group. Wave Capital’s investment strategy is heavily focused on backing startups at their earliest stages—often at the pre-seed and seed levels—where they help founders with everything from building their teams to finding product-market fit. This hands-on approach has positioned them as a key partner for marketplace startups, leveraging their strong networks within Silicon Valley to propel companies toward their Series A rounds and beyond. The firm’s portfolio is diverse, with investments in sectors ranging from blockchain and enterprise software to cleantech and e-commerce. Notable investments include companies like Locale, a food and grocery delivery platform, and Camus Energy, which focuses on renewable energy management systems. In total, Wave Capital has made 27 investments, with several successful exits, including Steady Health and Darwin Homes. Wave Capital’s team is known for its deep operational expertise and its ability to work closely with startups, offering more than just capital by being actively involved in guiding the companies they invest in​.

Wavelaunch VC is a New Delhi-headquartered global early-stage investment firm and three-month accelerator program founded in 2016 that backs founders 'solving difficult problems' at the pre-seed, seed and Series A stages. Despite its Indian operating base, Wavelaunch primarily deploys capital into US-based startups and runs two structured batches per calendar year, one from January to March and a second from June to August, combining a cohort experience with traditional equity investing. Tickets range from $500K to $4M for target ownership of 7 to 15%, and self-reported performance is an average 7.2x return multiple for early-stage investors; the firm generally participates as a co-investor. The fund is sector-agnostic with mandates spanning enterprise software, consumer internet, hardware, fintech, healthcare and beyond, and the disclosed portfolio touches more than two dozen sub-sectors. Headcount is small at approximately four people including two partners, with Arunav G. among the publicly visible team members. Standard databases track 42 disclosed portfolio companies, of which 20 are reported unicorns, alongside one IPO and twelve acquisitions, with marquee names including Indian fintech infrastructure platform Razorpay, social-commerce platform Meesho, and the iconic website builder Weebly, acquired by Square. The 3,000-plus figure cited on the firm's website refers to total applications and engaged founders across batches, not the equity portfolio. By combining a twice-yearly accelerator with traditional equity investing and focusing on US-based founders solving difficult problems, Wavelaunch VC has built an early-stage portfolio spanning fintech, consumer, hardware and healthcare.

Wavemaker 360 is a leading venture capital firm focused entirely on healthcare, investing primarily in seed-stage startups. Based in Pasadena, CA, and with an additional office in New York, Wavemaker 360 backs disruptors across health-tech, medical devices, telehealth, digital health, and AI-driven healthcare solutions. Notable investments include companies like UptimeHealth, Savonix, and xCures, with a portfolio spanning over 57 companies across two funds. Wavemaker 360's investment strategy emphasizes collaboration with its extensive network of healthcare-focused Limited Partners (LPs), including industry executives, providers, and organizations. This network gives portfolio companies direct access to expertise and strategic partnerships that help accelerate their growth. Their checks typically range from $250K to $500K, with reserves for follow-on funding. The fund is led by a seasoned team, including Founder John Nackel and General Partners Jay Goss and Eric Marton, who together have over 200 years of combined experience in healthcare and venture capital. Wavemaker 360 actively seeks entrepreneurs addressing major healthcare challenges, aiming to improve patient outcomes, reduce costs, and create new revenue streams for providers. Their approach blends capital investment with strategic support, helping startups navigate complex regulatory environments and scale rapidly​.

Wavemaker Partners is a leading early-stage venture capital firm with dual headquarters in Los Angeles and Singapore. The firm focuses primarily on enterprise, deep tech, and sustainability startups, especially in Southeast Asia and Southern California. Since its founding in 2003, Wavemaker has raised over $600 million and invested in more than 400 companies globally. Key investments include Moka (acquired by Gojek), Wavecell (acquired by 8x8), and Red Dot Payment (acquired by PayU). In Southeast Asia, the firm has been involved with startups like GudangAda, a B2B marketplace, and Transcelestial, which focuses on laser communications. Wavemaker is known for its emphasis on fintech, enterprise software, and deep tech, backing startups that address critical market needs with scalable solutions. Typically leading early rounds, Wavemaker provides financial backing and strategic support, with a strong interest in sectors like AI, quantum computing, and sustainability. Its cross-border presence and active investment strategy make it a major player in the global venture capital landscape.

Wealthing VC Club is a Palo Alto-based private investment community for accredited investors and family offices founded in 2020 by CEO Alicia Castillo Holley, with Daniel Chapellin Castillo as Co-Founder and Chief Operating Officer. The Club is intentionally selective: it surfaces approximately one curated deal per month for its members, a roughly 2% acceptance rate against deal flow, drawn from post-seed rounds that already have a signed term sheet from a credible lead VC and are scheduled to close within 30 to 45 days with at least 80% of the round filled. Members participate individually through syndicate vehicles, with personal allocations ranging from $5K to $500K, and the Club generally invests as a co-investor alongside the lead. Investment sectors span agtech, cybersecurity, life sciences, healthtech, fintech, mobility and space, and the typical instrument is a priced equity round or convertible note at Series A, B or C. The portfolio currently spans roughly 50 disclosed investments and 41 active companies, with four reported unicorns and five exits as of late 2025, including two IPOs and three acquisitions. The headline exit is BETA Technologies, the Vermont-based electric eVTOL aircraft company building sustainable urban air mobility, which completed a $1B-plus NYSE IPO on November 4, 2025. Beyond capital, Wealthing VC Club provides active strategic support to portfolio companies through its network of advisors, and a related Wealthing VC Fund vehicle for institutional participation. By curating a single high-quality, term-sheet-backed deal each month for accredited members, Wealthing VC Club gives investors selective access to later-stage venture rounds.

Weekend Fund, founded in 2017 by Ryan Hoover and Vedika Jain, is an early-stage venture capital firm based in San Francisco. The firm focuses on making initial investments of $100k to $300k in startups across various sectors, including FinTech, SaaS, AI/ML, and consumer products. Their diverse portfolio includes companies like Poparazzi, Batch, Supergreat, and MainStreet. Weekend Fund has made 100 investments to date, backing innovative startups like Superwall, EXTROPIC, and TrueMed. The firm has also seen successful exits with companies such as Awari, Supergreat, and Poparazzi. Their investment strategy is centered around supporting founders with product development, community building, and go-to-market strategies, leveraging their extensive network of 350+ LPs who are successful founders and operators. Key team members include Ryan Hoover, known for founding Product Hunt, and Vedika Jain, who bring a wealth of experience and a hands-on approach to nurturing startups from their earliest stages. The firm prides itself on fostering a collaborative environment that helps startups achieve scalable growth and long-term success.

WEH Ventures, founded in 2017 and based in Mumbai, is an early-stage venture capital firm focused on identifying and investing in companies solving India-first problems. The firm typically invests during the pre-seed and seed stages, with an average first-round check size of up to ₹3 crore. WEH Ventures operates with a sector-agnostic strategy, backing startups across various industries like fintech, e-commerce, gaming, and consumer products. The firm has successfully launched two funds. Fund I saw significant success, with over 90% of its portfolio companies raising follow-on capital from institutional investors, achieving a multiple on invested capital of around 4.2x. Some notable investments include Smallcase, Pratilipi, Trell, and Animall, showcasing WEH’s ability to identify high-growth companies. Their Fund II, launched in 2021 with a target corpus of ₹100 crore, continues this trajectory by backing companies like Unbox Robotics and Sustvest, with a strong focus on scalable solutions for the Indian market. WEH Ventures prides itself on being a hands-on partner to its portfolio companies, helping them navigate their growth journey with strategic guidance and follow-on support. This approach, combined with their deep understanding of the Indian startup ecosystem, has positioned WEH Ventures as a key player in fostering innovation and building sustainable businesses across the country.

Wellington Management is a global investment management firm that has expanded its private investing capabilities with a dedicated platform focusing on various sectors and stages of the private markets. This includes early-stage venture capital through to late-stage growth investments. With over $8 billion raised for private investments, the firm leverages its extensive network of over 1,000 investment professionals to provide comprehensive support to its portfolio companies. Wellington's venture capital arm, Wellington Access Ventures (WAV), recently closed its first early-stage fund, Wellington Venture Investments I, with $150 million in commitments. This fund focuses on investing in sectors such as artificial intelligence, DevOps, fintech, digital health, and consumer technology. The WAV team is dedicated to supporting diverse founder-led companies, recognizing the value in partnering with historically overlooked entrepreneurs to drive long-term growth and meaningful change. Key members of the WAV team include Jackson Cummings, Frederik Groce, Sasha McKenzie, and Van Jones. They emphasize closing the access and resource gaps in venture capital, aiming to create a more equitable future by investing in dynamic and ambitious founders from diverse backgrounds. Wellington Management's private investing platform combines deep private market expertise with the firm's broader public market knowledge, providing a robust support system for both investors and entrepreneurs.

Wellington Partners is a Munich-based venture capital firm, focusing on early- and growth-stage investments in life sciences. Established in 1998, the firm has been instrumental in backing innovative companies in biotechnology, medical devices, digital health, and diagnostics across Europe. With over €1.2 billion under management, including €590 million dedicated specifically to life sciences, Wellington Partners has a robust track record of supporting breakthrough technologies aimed at improving healthcare. Their portfolio includes successful companies like Carisma Therapeutics, Onward Medical, and Symetis, many of which have achieved successful IPOs or acquisitions. Wellington's investment strategy goes beyond capital infusion, offering extensive operational support and access to their global network to help startups navigate regulatory approvals, clinical development, and market expansion. The firm typically invests in the range of €0.5 million to €20 million per company and plays a hands-on role in scaling businesses globally, with a strong presence in key markets like Europe and the U.S. Through their dedicated team of MDs and PhDs, Wellington Partners continues to drive transformative healthcare innovations.

Westbound Equity Partners, formerly Concrete Rose Capital, is a venture capital firm headquartered in Menlo Park, California, committed to investing in startups led by underrepresented founders or building solutions focused on diverse communities. Launched initially in 2019, Westbound has grown its impact through its latest $100 million fund, which targets early-stage ventures with a mission to foster generational wealth and diversity in tech. Founders Sean Mendy and Ian Beadle, both seasoned investors, drive the firm’s approach, emphasizing cultural inclusivity and providing robust support through an extensive professional network that includes industry leaders like Andre Iguodala and Jeff Weiner. Westbound’s investment strategy emphasizes financial and social capital, with funds directed to companies demonstrating potential for both high impact and inclusivity, like Esusu and PlanetFWD. Each investment is bolstered by Westbound’s Talent Network, connecting founders with diverse talent pools and advising on company culture to enhance equitable team practices and inclusive product development. This social and financial support framework is designed to break cycles of underrepresentation in venture capital while achieving substantial returns. In addition to direct financial support, the firm reinvests 50% of its profits into minority communities through its foundation, reinforcing Westbound’s commitment to broad, enduring impact. This approach is set to challenge traditional investment structures by prioritizing long-term equity and inclusive growth alongside profitability.

The Western Development Commission (WDC), headquartered in Ballaghaderreen, Ireland, is a state agency dedicated to promoting social and economic development in the Western Region, covering counties such as Donegal, Leitrim, Sligo, Mayo, Roscommon, Galway, and Clare. The WDC provides both equity finance and loans to businesses, community projects, and social enterprises, aiming to foster innovation and growth in these areas. In 2023, WDC reported a record year of investments, with notable funding going to companies like Peroptyx (€500,000), Xerotech (€1.5 million), and Hooke Bio (€400,000). They also invested €200,000 in Magamedia for the TV series "Obituary" filmed in Donegal​. Other portfolio companies include Achill Island Sea Salt, AeroGen, Éire Composites, and Neuravi, highlighting WDC’s focus on sectors such as renewable energy, healthcare, and innovative manufacturing. The WDC supports its investments through a combination of commercial interest loans and strategic guidance, aiming to create a significant socio-economic impact in the Western Region.

Western Technology Investment (WTI) is a leading venture debt firm based in Portola Valley, California. Established in 1980, WTI has supported over 1,300 companies across various innovation sectors, providing more than $6 billion in financing. Notable investments include high-profile exits such as Planet, Kabbage, and Clover Health. WTI primarily focuses on technology and life sciences sectors, offering debt and lease financing to early and mid-stage companies. WTI’s investment strategy revolves around minimizing dilution while providing flexible funding options. They typically invest between $250,000 and $25 million, supporting companies from the initial stages to IPOs and beyond. This strategy allows startups to grow without giving up significant equity. The firm has a global reach, although it is particularly active in the U.S. market. The leadership team is spearheaded by Maurice Werdegar, who has been with WTI since 2001 and currently serves as the Chairman. The team also includes seasoned professionals like Patrick Ward, a principal and portfolio manager, and Maddy Burleson, a principal who joined after gaining experience in product marketing and GTM positioning. Startups seeking investment from WTI should demonstrate a clear path to growth and a solid business plan. The firm prefers detailed business submissions and often co-invests with other VCs to provide robust financial backing. WTI’s approach is founder-friendly, focusing on long-term partnerships and strategic support to drive success.

Westlake Ventures is a St. Petersburg, Florida-based investment firm founded in 2006. The firm is led and largely funded by Carl Treleaven, who serves as Principal, Chief Executive Officer, Treasurer and the registered agent on Florida corporate filings. Treleaven brings a deep operator background to investing, having spent nearly 20 years as CEO of Pharmagraphics, a multinational specialty packaging and label-printing company headquartered in Greensboro, North Carolina, and structures Westlake Ventures as a single-principal vehicle that co-invests alongside Florida angel groups, individual angel investors and selectively venture firms. Investment focus skews toward software and information technology, with additional activity in healthcare, biomedical and broader emerging-technology categories. Westlake principally backs development-stage companies based in Florida with innovative solutions to problems addressing large markets, although the portfolio also includes select non-Florida companies sourced through angel syndicates, and it generally invests as a co-investor. Across approximately 50 to 53 disclosed portfolio investments the firm has seen five acquisition exits, the most recent being teletherapy company TAO Connect, which was acquired by UpLift in March 2024. Public databases describe a wide nominal check-size range, but in practice individual ticket sizes are much smaller and reflective of seed and Series A angel-style co-investing. By pairing a seasoned operator's experience with co-investment alongside Florida angel networks, Westlake Ventures backs development-stage software, IT and healthcare founders, primarily in Florida, that target large markets with innovative solutions.

Westlake Village BioPartners is a venture capital firm based in Los Angeles, specializing in life sciences and biotechnology. Founded in 2018 by Beth Seidenberg, M.D., a former general partner at Kleiner Perkins, and Sean Harper, M.D., the firm has raised a total of $1.3 billion across three funds. Their most recent fund, launched in July 2023, raised $450 million to incubate and grow early-stage biotech companies. Westlake Village BioPartners focuses on transformative human therapeutic technologies, investing in companies from their early stages through Series B rounds. Their portfolio includes notable companies such as Latigo Biotherapeutics, which is developing non-opioid pain medicines, and Kyverna Therapeutics, which recently closed an upsized initial public offering. The firm is committed to catalyzing the Los Angeles biotech hub by supporting innovative startups and leveraging their extensive network and expertise in both scientific and business realms. Their leadership team includes experienced professionals like Mira Chaurushiya, Ph.D., and David Allison, Ph.D., who bring deep scientific and venture capital experience to the table.

WestTech Ventures is a Berlin-based hybrid investment firm founded in 2013 that operates in two complementary modes: as a direct pre-seed and seed venture capital investor backing B2B software founders in Germany and DACH, and as a Limited Partner and fund-of-funds partner committing to emerging European VC managers. The firm was founded by Masoud Kamali, a serial international entrepreneur best known for building Software & Support Media into a leading enterprise-tech media business starting in 1995, and is co-led on the investment side by Partner Fabian Leipelt, who has more than a decade of investing experience across both startups and fund commitments. Its direct-investment thesis sectors include automation, climate, future of work and digital health, all built on enterprise SaaS foundations, and tickets are sized for pre-seed and seed rounds, generally as a co-investor. The firm reports a team of approximately 13 people. Across roughly 60 to 81 disclosed direct and indirect investments, WestTech's portfolio has produced two IPOs and 18 acquisitions; named portfolio companies include Bird in micro-mobility, Marley Spoon in meal kits, Delivery Hero in food delivery, Climedo in clinical-trial software, which closed a EUR 5M seed led by Nauta Capital, Lumiform in digital inspections, MILES in mobility, Accure in battery analytics, GitButler in developer tools, Latana in brand tracking, and Opna in climate finance, WestTech's most recent reported investment in September 2023. By combining direct seed investing with fund-of-funds commitments, WestTech Ventures backs B2B software founders in the DACH region while supporting emerging European venture managers.

What If Ventures is a venture capital firm founded in 2020 that primarily invests in mental health, addiction, and stigmatized healthcare services. Based in the United States, What If Ventures is stage-agnostic and provides flexible check sizes, focusing on early-stage investments from seed to pre-IPO. Their portfolio includes companies like TRIPP, Osmind, Alto Neuroscience, Grow Therapy, and Ellipsis Health, which are all focused on innovative solutions in the mental health space. Notable exits include Human API and several IPOs, such as ATAI Life Sciences and Field Trip Health. What If Ventures has deployed $85 million in capital across 72 portfolio companies and has over 4,100 syndicate members. The firm supports startups by addressing the gaps and stigmas in mental health care, aiming to create accessible, affordable, and effective solutions for all.

White Star Capital is a global multi-stage venture capital firm that invests in technology startups with the potential to scale internationally. With a presence in key markets like New York, London, Paris, Toronto, and Singapore, White Star has developed a reputation for backing ambitious entrepreneurs building industry-defining companies across a variety of sectors. White Star focuses on investments in Series A and B rounds, supporting startups in industries such as fintech, digital assets, e-commerce, and healthtech. Some notable portfolio companies include Tier Mobility (a leader in micro-mobility solutions), Freshly (a healthy meal delivery service acquired by Nestlé), and Butternut Box (a fast-growing pet food company). In addition, the firm has made significant strides in blockchain and Web3 technologies through its Digital Asset Fund, which targets crypto networks and blockchain-enabled businesses. The firm’s investment strategy centers around partnering closely with founders, providing not just capital but also strategic support to help startups expand across borders. White Star is deeply committed to ESG (Environmental, Social, and Governance) principles, aligning its investments with sustainability goals. They became a signatory of the UN Principles for Responsible Investment, emphasizing their focus on creating long-term, positive impact. Led by co-founders Eric Martineau-Fortin and Jean-Francois Marcoux, the firm has successfully driven numerous exits, including Dollar Shave Club and Adore Me, reflecting their expertise in scaling companies to global success.

Whitecap Venture Partners, founded in 1990 and headquartered in Toronto, is a prominent early-stage venture capital firm. They focus on investing in B2B software, healthcare technology, and food technology companies across Canada and the Northeastern United States. Notable investments include Vetster, an innovative pet wellness platform, and PartnerStack, a sales technology platform. Whitecap has made significant exits, such as the IPO of Real Matters and the acquisitions of Affinio and Classcraft. Their investment strategy centers on partnering with founders to provide the necessary capital and guidance to scale their businesses successfully. Key team members include Carey Diamond, Russell Samuels, and Shayn Diamond, who bring extensive experience and expertise to the firm. With a track record of over three decades, Whitecap Venture Partners continues to support and grow startups by leveraging their deep industry knowledge and broad network. Their recent fund, Whitecap V, closed with commitments of CAD 140 million, emphasizing their commitment to fostering innovation and supporting early-stage companies in their growth journey.

World Innovation Lab (WiL) is a venture capital firm founded in 2014, with headquarters in Palo Alto, California, and Tokyo, Japan. WiL aims to bridge the gap between startups and large corporations, particularly focusing on cross-border innovation between the United States, Japan, and Asia. The firm is known for investing in both early-stage and later-stage companies, particularly in sectors like fintech, insurtech, automation, cybersecurity, cloud infrastructure, and health tech. WiL supports startups by establishing strong corporate partnerships, helping them scale globally, and facilitating collaboration with government entities in Japan and Asia. Their mission is to drive digital transformation and innovation within both startups and corporations, leveraging their expertise to foster growth and market expansion. The firm manages several funds, including WiL Ventures III, which has a focus on sustainability, climate tech, and Web3 technologies. WiL has made notable investments in companies such as Asana, Mercari, and Auth0, with successful exits including the acquisition of Auth0 by Okta. With over $1 billion raised in capital, WiL continues to be a key player in the venture capital ecosystem, fostering growth and innovation across geographies.

Wildcat Venture Partners is a Silicon Valley venture capital firm founded in 2015 and headquartered in San Mateo, California. Wildcat was co-founded by Bill Ericson, Bruce Cleveland, Bryan Stolle and Katherine Barr, with go-to-market thought leader Geoffrey Moore, author of Crossing the Chasm, serving as a Venture Partner, and an extended investment team including Nathaniel Krasnoff, Phyllis Whiteley, Brett Teele, Derrick Lee, Jennifer Trzepacz and Bill Davidow. The firm's investment thesis casts modern data-rich SaaS entrepreneurs as the 'wildcatters of the 21st century' who prospect, refine and monetize 'digital oil,' data, to become category-defining market leaders. Wildcat invests at early stage into B2B and B2B2C software companies applying machine learning and AI, IoT and cloud-and-mobility platforms in four core markets: Digital Health, EdTech, Enterprise SaaS and FinTech, and it is willing to lead. Fund I closed at $56.5M against an initial target of $100M, with Fund II targeting $120M, and Wildcat has a stated discipline of never raising a fund larger than $250M to preserve early-stage focus and ownership. Across 55 portfolio companies the firm has produced one unicorn, seven IPOs and 19 acquisitions, with named outcomes including Workday, Coupa, Doximity, Clover Health and Ritual, its latest exit in January 2025. The most recent reported investment was ZipLines Education's $6.4M Series A in February 2024. By framing data-rich SaaS founders as modern wildcatters and pairing capital with go-to-market expertise, Wildcat Venture Partners backs early-stage B2B software companies across health, education, enterprise and fintech.

Wildwood Ventures is a Denver, Colorado-based hybrid venture studio and early-stage fund founded in 2023 to back the next generation of companies sitting at the intersection of the outdoor economy and human wellness. The firm's thesis is explicitly counter-cyclical: the same digital technologies that have made modern society more connected, content-rich and convenient have also left people more sedentary, addicted, lonely and burnt out, and Wildwood backs founders building technology, brands and services that restore human connection, movement and time outdoors. The platform is run as a true studio plus fund: Wildwood invests capital and pairs portfolio companies with a one-year Entrepreneur-in-Residence engagement, with team members embedding as fractional cofounders to help shape product, brand, growth and go-to-market, and it is willing to lead. The senior team draws from deep operator backgrounds in the outdoor and wellness worlds. Founder and Managing Partner David Wagner spent 17 years at VF Corporation, the parent of The North Face and Vans, finishing with six years on the executive team. Founder and Partner Jesse Marble is the former CEO of growth-marketing firm Magneti, which he bootstrapped, scaled and exited; Principal and COO Kristen Gendron and Principal and Head of Growth David Krasny round out the senior team. Publicly disclosed portfolio companies include athlete mental-health platform Onrise, a Seed VC-II co-led with Crescent Ridge Partners in August 2025, Australian-origin patient-engagement platform Perx Health, a round disclosed in September 2025, and Sute. By combining a venture studio with early capital, Wildwood backs founders restoring movement, connection and time outdoors.

Will Ventures, founded by Isaiah Kacyvenski and Brian Reilly, is an early-stage venture capital firm based in Boston, Massachusetts. The firm focuses on investments across the consumer, healthcare, and media sectors, emphasizing companies that intersect with sports, fitness, and wellness. Their portfolio includes notable investments such as Mighty Health, Elo Health, and Candy Digital, showcasing their commitment to supporting innovative health and fitness solutions​. Will Ventures employs a hands-on approach, actively leading investment rounds and providing strategic support to their portfolio companies. They typically invest in seed and Series A stages, with an average round size of $8 million. Their investment strategy is driven by a deep understanding of the sports and health sectors, leveraging their extensive network and expertise to help startups scale and succeed. The firm is particularly interested in startups that offer scalable, technology-driven solutions in the areas of fitness, nutrition, and digital health. Companies looking to partner with Will Ventures should prepare a concise pitch that highlights their innovative approach, market potential, and strategic fit with Will Ventures' focus areas. With a track record of successful investments and a robust support system, Will Ventures continues to drive impactful advancements in the health and wellness industries.

Willow Growth Partners is a Los Angeles-based early-stage venture capital firm that focuses on investing in emerging consumer brands and the technologies that support them. Founded in 2020 by Deborah Benton and Amanda Schutzbank, the firm aims to back companies that are not only innovative but also values-driven, with a strong emphasis on sustainability and transparency. The firm’s investment strategy is centered around supporting brands with strong underlying unit economics and a clear path to profitability. Willow Growth Partners typically leads the first institutional round of investment and provides extensive hands-on support, helping companies scale efficiently while maintaining their core values. Their inaugural $28 million fund, announced in 2021, reflects this approach, with a portfolio that includes companies like Bubble, Dae, and Coterie, among others. Willow Growth Partners is particularly committed to diversity, with nearly 75% of their portfolio companies led by female or minority founders. The firm’s founders bring a wealth of experience from both venture capital and operating roles, which they leverage to guide their portfolio companies through the challenges of early-stage growth.

Windham Venture Partners, founded in 2006 and headquartered in New York City, focuses on early-stage investments in the healthcare sector, particularly in medical technology, digital health, and life sciences. The firm is dedicated to investing in companies that bring significant advancements and innovations in healthcare, emphasizing transformative impact and commercialization of cutting-edge technologies. Their notable investments include companies like Alto Neuroscience, Valera Health, and SubjectWell. Windham Venture Partners has achieved successful exits with companies such as CVRx, which went public, and SubjectWell, acquired by WindRose Health Investors. The firm has made 74 investments and has seen 25 exits, showcasing a robust portfolio and strategic investment approach. Led by co-founders Roger Fine, Adam Fine, and Joseph Proto, Windham Venture Partners brings together a team of experienced professionals dedicated to supporting their portfolio companies with strategic guidance and resources. The firm collaborates with a wide range of co-investors, enhancing its ability to back high-impact ventures and drive innovation in healthcare​.

Wing Venture Capital, founded in 2013 and based in Palo Alto, California, focuses on early-stage investments in technology companies. The firm primarily invests in sectors such as AI, cybersecurity, big data, SaaS, and enterprise software. Wing is known for its deep engagement with founders, providing extensive support beyond capital to help build significant companies. Notable companies in Wing's portfolio include Snowflake, a data cloud company; Cohesity, a data management firm; and Gong, which uses AI to analyze sales calls. Other prominent investments are Pinecone, a vector database company, and Moogsoft, an AIOps platform for IT incident management. Wing's investment strategy emphasizes long-term partnerships with founders, leveraging their expertise and extensive network to support the growth of portfolio companies. They aim to be actively involved, often taking board seats and providing strategic guidance.

Winklevoss Capital, founded by Cameron and Tyler Winklevoss, is a New York-based family office that invests in early-stage startups across various sectors. The firm has a particular focus on fintech, direct-to-consumer brands, education, and gaming. Notable investments include Flexport, Kindbody, and Animoca Brands, which exemplify their diverse and high-impact portfolio. Their investment strategy is characterized by supporting entrepreneurs who aim to create a "frictionless world," providing not only capital but also valuable guidance and connections. They typically engage in seed and Series A funding rounds, often leading these rounds and writing checks that range from $1M to $5M. Geographically, Winklevoss Capital has a global outlook, with investments spanning across North America, Europe, and Asia. They have shown a strong presence in the fintech space, notably with their significant stake in Gemini, a major cryptocurrency exchange they also founded. Other notable investments include BitInstant, Protocol Labs, and Filecoin, highlighting their early and ongoing commitment to blockchain and cryptocurrency ventures. The team at Winklevoss Capital leverages their entrepreneurial experience and extensive network to help startups grow and scale. Entrepreneurs looking to secure investment should emphasize their innovative approaches and potential for significant market impact. The firm prefers to engage with founders who have a clear and compelling vision, backed by strong execution capabilities.

Wintrust Ventures is the corporate venture capital arm of Wintrust Financial Corporation, the Rosemont, Illinois-headquartered community-banking and financial services holding company founded by Edward J. Wehmer that operates roughly 15 wholly-owned chartered banking subsidiaries across greater Chicago and southern Wisconsin alongside wealth-management and specialty-lending businesses. Established in 2015, Wintrust Ventures is led by Senior Vice President Bailey Moore, who launched the unit at age 28 and continues to head it; in February 2022 Wintrust Financial committed an additional $50 million of capital to the Ventures program to extend its support of Chicago's innovation community. The unit's thesis pairs financial-services value-add, banking, specialty financing, wealth-management and treasury services for both portfolio companies and their founders, with equity investment, primarily into Late Seed and Series A rounds, generally as a co-investor. Sector focus areas include Enterprise SaaS, Healthcare IT, Marketplaces and Omni-Channel consumer brands, with a strong Chicago and Midwest bias. Since inception Wintrust Ventures has made approximately 52 to 102 investments depending on the database, across 42 active high-growth portfolio companies. Named investments include workforce platform The Mom Project, smart-buildings software Cohesion, specialty grocery and prepared-foods retailer Foxtrot Marketplace, premium kids' brand Monica + Andy, and direct-to-consumer furniture brand Interior Define. The Ventures program's largest historic exit on record is Megalytics, in October 2019. By pairing equity with a full suite of banking and financial services, Wintrust Ventures backs Chicago and Midwest founders across SaaS, healthcare IT, marketplaces and consumer brands.

Wireframe Ventures is a venture capital firm founded in 2016, with headquarters in Mill Valley, California, and an expanded presence in New York City. The firm focuses on pre-seed and seed-stage investments, particularly in sectors that positively impact climate and health. Their mission is to back founders driven by a commitment to create innovative solutions that benefit people and the planet. Wireframe Ventures manages several funds, including the recently announced $77 million Wireframe Fund II. This fund is dedicated to supporting early-stage companies aiming to improve environmental sustainability and healthcare. The firm typically invests between $500,000 and $2 million in early-stage companies, often leading or participating in high-quality syndicates. The team at Wireframe Ventures includes co-founders Harsh Patel and Paul Straub, along with other key members such as Lily Bernicker. They bring extensive experience and a hands-on approach to support their portfolio companies from the initial investment through to product-market fit and subsequent funding rounds. Notable investments by Wireframe Ventures include Mammoth Biosciences, SPAN.io, MycoWorks, Electriphi, and Enveda Biosciences. These companies exemplify Wireframe's focus on innovative technologies that address critical issues in health and sustainability. The firm has a strong track record, with over 70% of their portfolio companies raising institutional Series A funding within 15 months of Wireframe's initial investment.

Wisdom Ventures is a unique venture capital firm founded with a mission to promote mindfulness, well-being, and human connection through its investments. The firm recently closed its first fund, raising $10 million in an oversubscribed round. The fund supports early-stage companies across sectors like mental health, AI, and workplace well-being, with notable investments in startups such as Betterleave, Alkeme, and Seven Starling. Wisdom Ventures is dedicated to nurturing a new paradigm where technology and business serve humanity rather than profit from division and addiction. Led by a team of seasoned professionals, including long-time Google executive Bradley Horowitz, meditation teacher Jack Kornfield, and well-being expert Ruchika Sikri, the firm blends capital with a commitment to personal growth and conscious leadership. The fund has attracted investors such as Reid Hoffman and Evan Williams, aligning with its vision of fostering a compassionate and mindful entrepreneurial ecosystem. Wisdom Ventures places a strong emphasis on diversity, with 50% of its Limited Partners and 80% of its founders representing diverse backgrounds. As the firm looks ahead, it plans to continue supporting aligned founders while preparing for a larger Fund II.

Wittington Ventures is the venture capital arm of Wittington Investments Ltd., the holding company of Canada's billionaire Weston family, the controlling shareholders of George Weston Limited, Loblaw Companies Limited (Canada's largest grocery retailer), Shoppers Drug Mart and Choice Properties REIT. Founded in 2019 and headquartered in Toronto, Wittington Ventures pairs equity capital with privileged access to one of North America's most iconic strategic ecosystems in retail, healthcare, real estate and financial services, and it is willing to lead. Managing Partner Jim Orlando, who joined the firm in 2019 after spending 11 years at OMERS Ventures, leads a focused four-person team that includes Partner Jodi Kessler, based in New York, and Partner Zeeshan Ali. Wittington runs several themed pools, including a $100M dedicated fund for health and climate innovation research and a $100M 'Made-in-Canada' fund providing equity and debt financing to domestic food suppliers, and the broader Ventures mandate spans business products and services, consumer products and services, healthcare, e-commerce and mobile commerce, and emerging technology, primarily across North America. As of April 2026, Wittington has invested in 17 companies with three new investments in the last twelve months. Recent activity has been especially weighted to healthcare AI: Wittington led the $10M Series A of clinical-interoperability platform WellBeam in November 2025, participated in the $40M Series B of clinical-access AI Doctronic in March 2026, and is a backer of unicorn-status Abridge in generative AI for clinical documentation. By pairing capital with the Weston family's strategic ecosystem, Wittington Ventures backs retail, healthcare and consumer founders.

WNT Ventures is New Zealand's deep-technology venture capital investor, founded in 2014 with operating offices in Tauranga in the Bay of Plenty and Auckland. The firm was selected in 2014 as one of only three pilot Technology Incubator partners under the Callaghan Innovation Deep Tech Incubator Programme, the longest-running such partnership in the country, and was subsequently re-awarded a continuing contract under the revised eight-year program. WNT is led by Managing Partner Carl Jones alongside Partner Maria Jose Alvarez, and the team works closely with founders out of New Zealand's universities and Crown research institutes to commercialize tangible science and engineering breakthroughs that can be 'seen, felt or touched' rather than purely software, and it is willing to lead. Its sector focus is intentionally broad within deep tech: agritech, food and horticulture tech, cleantech and climate tech, marine sciences, materials and advanced manufacturing, robotics, aerospace, engineering and automation, sustainability and commodity recycling, medical devices and tools, and selectively AI. WNT has raised four funds to date, with Funds I and II producing strong net returns of roughly 20% and 25% net annual respectively, Fund III deployed across deep tech, and the newly announced Fund IV targeting $35M to $40M. Across approximately 28 disclosed investments, the broader Callaghan-supported program has fostered more than 84 deep-tech NZ startups with a 72% survival rate. Named portfolio companies include CarbonScape, carbon-negative biographite for EV battery anodes, and CarbonCrop, native-forest carbon monitoring. WNT Ventures commercializes New Zealand's science and engineering research.

Woodstock Fund is a global venture capital firm with a sharp focus on blockchain technology, decentralized finance (DeFi), and Web 3.0 ecosystems. Founded in 2019, the firm has quickly built a strong portfolio across early and growth-stage companies in sectors such as decentralized protocols, NFTs, and tokenization. Notable investments include Router Protocol, a cross-chain liquidity platform, Transak, a crypto on-ramp provider, and Covalent, a blockchain data querying service. The fund is headquartered in the Cayman Islands with offices in India and the UAE, bridging investment opportunities between Asia, the Middle East, and global markets. Woodstock's investment strategy is highly research-driven, with a focus on emerging technologies that push the boundaries of Web 3.0. They target startups in Series A and pre-seed stages, with check sizes ranging from $1M to $5M. The firm is also active in infrastructure and protocol development, helping to shape governance and ecosystem growth for the projects they back. Woodstock’s investment horizon is long-term, often employing a five-year lockup period for their investors. Led by co-founders Pranav Sharma and Himanshu Yadav, Woodstock Fund has gained a reputation for its deep expertise in decentralized technologies and its hands-on approach to supporting portfolio companies. This commitment is reflected in its strategic role in building infrastructure around blockchain and guiding early-stage startups through the complex landscape of decentralized ecosystems.

Work-Bench, established in 2013 and based in New York City, focuses on early-stage investments in enterprise technology startups. The firm is known for its thesis-driven approach, investing in companies that address significant pain points within Fortune 500 IT departments. This strategy leverages Work-Bench's extensive corporate network to validate investment opportunities before committing capital. Work-Bench primarily invests in sectors like data, AI, machine learning, infrastructure, developer tools, cybersecurity, and enterprise applications. Notable investments include Cockroach Labs, Socure, and Dialpad, which have significantly impacted their respective industries. Other key portfolio companies include RippleMatch, an AI-driven recruiting platform, and FireHydrant, a comprehensive incident management solution. The firm typically leads seed and Seed II rounds, with investments ranging from $3 million to $6 million. Work-Bench’s third fund, which closed at $100 million, underscores its commitment to supporting early-stage enterprise software startups and helping them scale through targeted go-to-market strategies. This includes utilizing their network to secure early customer engagements and sharing best practices through community events and playbooks. Work-Bench's portfolio reflects a strong emphasis on building long-term relationships with founders who have firsthand experience in enterprise technology. Their approach has resulted in numerous successful exits, such as CoreOS and Algorithmia.

World Trade Ventures (WTV) is an early-stage venture capital firm founded in 2016 and headquartered in New York City, with operational links to Tel Aviv and Stamford. The firm is embedded with SilverTech Ventures, a Silverstein-backed startup incubator originally located at the World Trade Center campus, which gives WTV deep deal-flow ties to Israeli tech founders moving into the US market. WTV invests primarily at the Series A stage in US-based startups and targets companies bridging the physical and digital worlds across enterprise software, fintech, AI and ML, cybersecurity, marketing technology and digital health, generally as a co-investor. The portfolio includes more than 21 companies, with one unicorn, Semperis in Active Directory identity protection, which crossed the $1B valuation threshold in 2024. Other named portfolio companies include Aquant, SQream, Lili, Fundrise, Reveal Security, Alma Security, Zest, AvoMD, Visit.org, Vi, SwiftConnect, Sepio, Covercy, City Hive, Igentify, WoodSpoon and HYPR Brands. Exits to date include Semperis as a unicorn, Julius via acquisition, and HYPR Brands in May 2020. The firm operates with a small team of roughly four people including three partners. Fund size is not publicly disclosed; check sizes are consistent with a typical seed-to-Series A boutique fund participating alongside larger lead investors. By leveraging its incubator ties to Israeli founders entering the US and focusing on companies bridging physical and digital worlds, World Trade Ventures backs early-stage enterprise software, fintech, cybersecurity and digital-health companies.

WorldQuant Ventures is an early-stage venture capital firm founded in 2014 by Igor Tulchinsky. The firm primarily focuses on disruptive technologies in data, finance, healthcare IT, AI/ML, quantum computing, and space. Based in Old Greenwich, Connecticut, WorldQuant Ventures supports its portfolio companies through strategic advice and introductions, leveraging its extensive experience in technology and data science​. Notable investments include companies like Dataminr, Pico, Credijusto, Benzinga, IonQ, PsiQuantum, Genies, and Skyroot. The firm typically invests at the pre-seed, seed, and Series A stages, with an emphasis on being long-term partners to their portfolio companies​. WorldQuant Ventures is managed by Steve Lau, who brings significant expertise from his background in financial technology and trading. The firm also benefits from the strategic vision of its founder, Igor Tulchinsky, who has a rich history in quantitative trading and venture capital​.

Worth Capital is a UK-based venture capital firm that specializes in early-stage investments, focusing on startups with innovative, market-disrupting products or services. They typically invest up to £400,000 in businesses that qualify for the Seed Enterprise Investment Scheme (SEIS) or Enterprise Investment Scheme (EIS). Their investment approach centers around identifying brands that have strong potential for growth and customer loyalty, particularly those operating in fragmented or underserved markets. Worth Capital’s portfolio is diverse, covering both B2B and consumer sectors. Notable investments include Fox Robotics, an agricultural technology company, and Kanda, a fintech solution for tradespeople. The firm values market insight and problem-solving over mere technological hype, emphasizing the importance of founders who understand their markets deeply. Geographically, Worth Capital is committed to supporting UK-based startups, with a significant portion of their investments going to businesses outside of London. Their founders, Matthew Cushen and Paul Soanes, bring decades of entrepreneurial and investment experience, providing not only capital but strategic guidance to help their portfolio companies scale successfully. For startups looking to engage, Worth Capital values clear market strategies and innovation, with a preference for businesses aiming to build enduring, loved brands​.

WuXi Healthcare Ventures was founded in 2011 as the corporate venture arm of WuXi PharmaTech, now WuXi AppTec, the China-based contract research and manufacturing giant. The firm was headquartered in Cambridge, Massachusetts with a second office in Shanghai, China, and ran an explicit cross-border 'find in U.S. and build in China' strategy, identifying promising life sciences companies in the US and supporting their development with access to the China market and WuXi's R&D platform, generally as a co-investor. WuXi Healthcare Ventures II, L.P. closed in December 2015 at $290 million, exceeding its $250M target. Founding leadership included Dr. Ge Li, founder of WuXi PharmaTech, and Edward Hu, CFO/CIO of WuXi AppTec, as non-operating partners, and operating partners including Managing Partner Wei Li. The portfolio spanned both US biotechs and emerging Chinese drug developers, including Twist Bioscience, Unity Biotechnology, Ideaya Bioscience, Syros Pharmaceuticals, CStone Pharmaceuticals, Hua Medicine, Antengene Corporation, Refuge Biotechnologies, XW Laboratories, LifeMine Therapeutics, Vivace Therapeutics and Forerunner Medical. The firm exited several landmark companies including Agios Pharmaceuticals in cancer metabolism, Foundation Medicine, later acquired by Roche, and Juno Therapeutics, later acquired by Celgene. On May 18, 2017, WuXi Healthcare Ventures merged with Frontline BioVentures to form 6 Dimensions Capital, an approximately $800M AUM biotech-focused VC chaired by Ge Li with Frontline founder Dr. Leon Chen as CEO. New investment activity is now conducted under the 6 Dimensions Capital brand. With its cross-border model, WuXi Healthcare Ventures bridged US life-sciences innovation and the China market.

WVV Capital is a $100 million venture capital firm based in Milwaukee, Wisconsin, founded in 2018. The firm is a joint partnership between major corporations like Advocate Aurora Health, Foxconn, Johnson Controls, and Northwestern Mutual. WVV Capital focuses on investing in early-stage startups across healthcare, manufacturing, financial services, and building technologies, often targeting ventures that harness artificial intelligence and advanced data solutions. WVV Capital offers more than just funding—its unique approach involves building strategic relationships between startups and large corporations, facilitating growth through data partnerships and corporate support. Their portfolio includes companies like Caspar AI and Paxton AI, which focus on healthcare and productivity technologies, respectively. The firm has a diverse and experienced team, led by professionals like Jason Franklin, Ph.D., and Danielle D’Agostaro, both with extensive backgrounds in venture capital and startup operations. With a strong emphasis on AI-driven innovation, WVV Capital aims to bridge the gap between cutting-edge startups and data-rich corporations, helping companies scale effectively in competitive industries. Their broad network of corporate partners and seasoned operators allows them to support startups from initial investment through to large-scale growth.

The WXR Fund is a unique venture capital firm that targets two of the most significant opportunities in today's technology landscape: spatial computing and female entrepreneurship. Founded in 2019, WXR Fund is the first venture fund exclusively focused on investing in women-led startups that leverage extended reality (XR) and artificial intelligence (AI) technologies to transform businesses and human interaction. The firm is committed to fostering diversity in tech by supporting female founders who are pioneering the next wave of computing. WXR Fund operates with a seed-stage investment strategy, partnering with startups that are at the forefront of innovative technologies. The fund's portfolio includes a range of groundbreaking companies, such as Prisms of Reality, an educational technology company that uses virtual reality to enhance STEM learning, and Scatter, which is democratizing hologram creation through its volumetric video production software, Depthkit. The fund’s leadership, including co-founders Martina Welkhoff, Amy LaMeyer, and Malia Probst, is dedicated to creating an inclusive ecosystem that not only funds but also mentors and supports women entrepreneurs in the tech industry. With its focused approach, WXR Fund is actively changing the way products are built and companies are run, making a significant impact on both the tech and venture capital landscapes. This fund stands out not only for its niche focus but also for its broader mission to balance gender representation in the tech industry, positioning itself as a key player in the future of spatial computing and AI​.

Xenia Venture Capital is an Israeli high-tech and life sciences investment company founded in 2003 and publicly traded on the Tel Aviv Stock Exchange. Headquartered in Tel Aviv, Xenia invests in early-stage Israeli companies across high-tech and medical technology, with an increasing focus on life sciences. A core element of its platform is a 50% stake in VLX, a technological incubator operating under the Israel Innovation Authority's incubator program that supports data-driven biotech, pharma and digital-pharma startups. Beyond capital, Xenia provides portfolio companies with mentoring, business and strategic counseling, fundraising assistance, exit planning, and shared back-office infrastructure, finance, accounting, logistics and office support, services well suited to first-time scientific founders coming out of academia or the Israeli Innovation Authority incubator pipeline, and it generally invests as a co-investor. Since inception the firm has invested in more than 40 companies and notched one IPO and at least six acquisitions; flagship outcomes include the June 2020 NASDAQ IPO of PolyPid at roughly a $273M market cap, the acquisition of orthopedic device company OrthoSpace by Stryker, and the 2021 exit of MEC software vendor Saguna. Recent activity remains steady, with its most recent reported investment on April 8, 2025 in Arcuro Medical in surgical devices. The firm's leadership has included CEO Lars Thoren and previously Eli Sorzon, and the team comprises roughly eight people including seven partners. By pairing capital with incubation and back-office support, Xenia Venture Capital backs early-stage Israeli high-tech and life-sciences founders.

XFactor Ventures, founded in 2017 and based in New York, is a venture capital firm that focuses on pre-seed and seed-stage investments in companies with at least one female founder. Their mission is to support ambitious entrepreneurs who possess the "X Factor" and the drive to build billion-dollar companies. The firm is known for backing diverse and innovative startups across various sectors, including health tech, AI, e-commerce, and enterprise software. XFactor Ventures has made significant investments in companies like Chief, a private network for women leaders, and MixLab, a provider of personalized pet medications. They have seen successful exits from companies such as Clara Labs, The Inside, and Park Place Payments. The team at XFactor Ventures includes experienced entrepreneurs and investors like co-founders Anna Palmer and Charles Hazard Jr. The firm prides itself on a hands-on approach, providing invaluable resources and guidance to help founders navigate challenges and scale their businesses effectively. XFactor Ventures is part of the Flybridge Capital Partners community, which offers additional support and resources to its portfolio companies. The firm encourages concise and clear pitches from startups that align with their investment focus​.

Xfund is an early-stage venture capital firm that supports lateral thinkers and entrepreneurs who experiment across disciplines. Established in 2014 through a unique partnership with leading venture capital firms and top research universities, Xfund is co-managed by Patrick Chung and Brandon Farwell. The firm focuses on backing founders with multidisciplinary skills and a strong commitment to innovation and execution. Xfund aims to invest in individuals who are not only technically proficient but also possess a deep understanding of their field's broader implications. Their investment approach is designed to provide significant value through a combination of venture capital expertise, university partnerships, and industry connections. This structure allows Xfund to offer unparalleled support to its portfolio companies. The firm has raised several funds, including the latest, Xfund 3, which closed at $120 million. This fund continues Xfund's mission of fostering university-based innovation and supporting startups across various stages of growth. Xfund's notable investments include companies like Philo, Kensho, and 23andMe, reflecting their commitment to high-impact ventures. Xfund operates out of Cambridge, Massachusetts, and Palo Alto, California, reinforcing its connection to leading academic and innovation hubs. For more information, you can visit their official website at xfund.com.

Xista Ventures is a venture capital firm that focuses on transforming groundbreaking scientific discoveries into commercial ventures. With a strong emphasis on biotech, medtech, and deep tech, Xista operates out of Austria, leveraging its close ties to the Institute of Science and Technology Austria (ISTA). Their portfolio includes innovative companies like Prewave, which uses AI to predict supply chain risks, and VALANX Biotech, known for its precise protein conjugation technology. Xista primarily invests in early-stage startups, guiding them through critical processes such as university agreements, corporate partnerships, and securing funding. Their focus is on startups with a clear impact on human and planetary health. Typical investment stages range from pre-seed to Series A, with Xista often leading rounds. Their companies have raised over €200 million in grants and equity. Founders benefit from continuous support, from due diligence to strategic scaling, with Xista emphasizing long-term partnership and success.

Xplorer Capital, founded in 2011 and based in Menlo Park, California, focuses on investing in early-stage B2B companies that are transforming traditional industries on a global scale. The firm invests across various sectors, including agricultural technology, logistics, healthcare, and advanced manufacturing. Notable investments by Xplorer Capital include Zipline, a leading provider of drones for on-demand delivery services, and FarmWise, which develops robotic equipment for automating weeding on vegetable farms. The firm has also invested in Bigfoot Biomedical, which develops automated insulin delivery systems, and Cargomatic, an on-demand trucking marketplace. Other significant portfolio companies include Wingcopter, known for its innovative drone technology, and Zoox, which offers autonomous mobility solutions. Xplorer Capital's investment strategy involves supporting companies through seed, Series A, and Series B rounds, aiming to leverage their extensive experience and connections to help portfolio companies succeed. The firm emphasizes forming long-term partnerships with entrepreneurs and disruptive technologies that can have a transformative impact on their respective industries​.